fr

CARMAT announces its participation in several scientific and investor conferences during the 1st half of 2025

Continuation, in France, of the clinical trial on the first bioprosthetic artificial heart

Download

2013 annual results

Download

CARMAT publishes its fifth Shareholder Newsletter

Download

First-in-man implantation of CARMAT's bioprosthetic artificial heart

Download

CARMAT is participating in the EACTS Annual Meeting in Vienna (Austria)

Download

CARMAT obtains ANSM approval in France to carry out the first human implants of its artificial heart

Download

H1 2013 financial results

Download

CARMAT publishes its fourth Shareholder Newsletter

Download
Top of page